Enantioselective disposition of lansoprazole in relation to CYP2C19 genotypes in the presence of fluvoxamine

AIMS: Lansoprazole is affected by polymorphism of CYP2C19. The aim of this study was to examine the effects of fluvoxamine, a CYP2C19 inhibitor, on the pharmacokinetics of each lansoprazole enantiomer among three different CYP2C19 genotype groups. METHODS: Eighteen healthy subjects, of whom six each...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Miura, Masatomo, Tada, Hitoshi, Yasui-Furukori, Norio, Uno, Tsukasa, Sugawara, Kazunobu, Tateishi, Tomonori, Suzuki, Toshio
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Blackwell Science Inc 2005
Konular:
Drug Disposition
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC1884909/
https://ncbi.nlm.nih.gov/pubmed/15963095
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2005.02381.x
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller